Frew

Department of Medicine I
Centre for Translational Cell Research

1994-1997 B.Sc (Hons. In Molecular Biology and Biochemistry), Australian National University, Canberra, Australia
1998-2003 PhD, Peter MacCallum Cancer Center, University of Melbourne, Australia
2003-2009 Postdoctoral scientist, Institute of Cell Biology, ETH Zurich, Switzerland
2010-2016 Swiss National Science Foundation Assistant Professorship, Institute of Physiology, University of Zurich, Switzerland
Since 2017 Full Professor (W3) of Oncogenic Signalling, Medical Center - University of Freiburg

Harlander S, Schönenberger D, Toussaint NC, Prummer M, Catalano A, Moch H, Wild PJ and Frew IJ. Combined Vhl, Trp53 and Rb1 mutation causes clear cell renal cell carcinoma in mice. Nature Medicine. 2017; 23: 869-877.
Schönenberger D, Harlander S, Rajski M, Jacobs RA, Lundby AK, Adlesic M, Hejhal T, Wild PJ, Lundby C and Frew IJ. Formation of renal cysts and tumours in Vhl/Trp53 defi cient mice requires HIF1alpha and HIF2alpha. Cancer Research. 2016; 76:2025-2036.
Albers J, Danzer C, Rechsteiner M, Lehmann H, Brandt L, Hejhal T, Catalano A, Busenhart P, Gonçalves AF, Brandt S, Bode PK, Bode-Lesniewska B, Wild PJ and Frew IJ. A versatile modular vector system for rapid combinatorial mammalian genetics. Journal of Clinical Investigation. 2015; 125:1603-19.
Lehmann H, Vicari D, Wild PJ and Frew IJ. Combined Vhl and Kif3a deletion accelerates renal cyst formation. Journal of the American Society of Nephrology. 2015; 26:2778-88.
Albers J, Rajski M, Schönenberger D, Harlander S, Schraml S, von Teichman A, Georgiev S, Wild PJ, Moch H, Krek W and Frew IJ. Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice. EMBO Molecular Medicine. 2013; 5:949-64.